Yang-si P. Li
Guangzhou, 510080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
FUS inactivation promotes leptomeningeal metastasis of lung cancer through the up-regulation of CD36.
Journal: Science translational medicine
Published: August 26, 2026
Cellular dynamics in cerebrospinal fluid unveils the key regulators of intracranial response to immune checkpoint inhibitors in NSCLC brain metastases.
Journal: Journal for immunotherapy of cancer
Published: October 26, 2025
Incidence and spectrum of immune-related adverse events in nasopharyngeal carcinoma patients treated with immune checkpoint inhibitors.
Journal: Med (New York, N.Y.)
Published: September 25, 2025
Response to Letter to the Editor: "Refining Immunochemoradiotherapy for Patients With NSCLC and Brain Metastases: Insights on Biomarkers, Neuroprotection, and Global Applicability".
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 27, 2025
Efficacy and safety of induction immunotherapy plus chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a meta-analysis.
Journal: British journal of cancer
Published: May 07, 2025
Chemoimmunotherapy as induction treatment in concurrent chemoradiotherapy for patients with nasopharyngeal carcinoma stage IVa.
Journal: Annals of medicine
Published: January 21, 2025
First-Line Camrelizumab Versus Placebo Plus Chemotherapy With or Without Radiotherapy for Brain Metastases in NSCLC: The CTONG 2003 Randomized Placebo-Controlled Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 12, 2024
PEARL: A Multicenter Phase 2 Study of Lorlatinib in Patients with ALK-Rearranged NSCLC and Central Nervous System Disease.
Journal: Clinical lung cancer
Published: October 09, 2024
Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial.
Journal: JAMA oncology
Published: June 13, 2024
Combination of Cytologic Findings and Circulating Tumor DNA From Cerebrospinal Fluid Revealed SCLC Transformation in Patients With Leptomeningeal Metastases of Lung Adenocarcinoma.
Journal: JTO clinical and research reports
Published: March 21, 2024
Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases.
Journal: Nature medicine
Published: November 17, 2023
Last Updated: 09/26/2026